Project Grant R43DA059318
Award Date 7/1/24
Completion Date 6/30/25
Dollars Obligated $646K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New Jersey, USA
Similar Awards
- This federal Project Grant award of $489,500.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to evaluate the use of remote oral fluid testing to assess cannabis non-use in clinical trials involving younger adults aged 18-30 years. The key products or services to be delivered through this 2-year project, which runs from June 1, 2025 to May 31, 2027, include: Evaluating the completion and performance of daily oral fluid...
- The federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is aimed at developing a method for capturing and concentrating exhaled breath aerosols using electrostatic charging and precision collection. The $587,936 award to Vox Biomedical LLC, a for-profit limited liability company in Bedford, MA, will fund research to improve the detection sensitivity of trace amounts of tetrahydrocannabinol (THC) and other...
- This $586,936 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of a low-cost, disposable urine test strip that can rapidly and quantitatively measure substance use disorder (SUD) medication drugs and their metabolites. The award recipient, Vitan-Biotech LLC, will create a point-of-use lateral flow assay (LFA) test strip that leverages innovative signal amplification technology to...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is supporting the development of a software-based medical device (SAMD) for detecting opioid use through voice analysis. The $800,000 award to Tenvos Inc., a minority-owned and woman-owned technology company, aims to advance the company's AI-driven solution that can enable patients to remotely test for opioid use and securely share results with...
- The U.S. National Institute on Drug Abuse (NIDA) awarded Altrumed LLC a $404,078 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop a device-agnostic hypoxia detection software for opioid overdose prediction and positive reversal monitoring. The project, titled "DEVICE-AGNOSTIC HYPOXIA DETECTION SOFTWARE FOR OVERDOSE PREDICTION AND POSITIVE REVERSAL MONITORING," aims to create an innovative wearable sensor system that integrates advanced...
- This $668,110 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The project aims to refine an existing intervention that provides information on cannabis products, marketing, laws, and risks to increase young adults' cannabis literacy. The research will involve focus groups with...
- The National Institute of Justice (NIJ) awarded a $726,360 Project Grant to Virginia Commonwealth University (VCU) under the Comprehensive Opioid, Stimulant, and other Substances Use Program (COSSUP), CFDA 16.838. The funding will support VCU's efforts to address analytical challenges with proliferating commercially available THC analogues. Key project activities include monitoring e-liquids to identify emerging THC analogs, developing and validating analytical methods for product and biological...
- The National Institute on Drug Abuse (NIDA), through the Drug Use and Addiction Research Programs (CFDA 93.279), has awarded a $684,694 Cooperative Agreement to New York University (NYU) to develop and evaluate a novel home-based intervention combining transcranial direct current stimulation (tDCS) with mindfulness meditation for the treatment of cannabis use disorder (CUD). The project, titled "Telehealth-Delivered tDCS for Cannabis Addiction Recovery: The C.A.R.E.S. (Cannabis Addiction...
- This Project Grant from the Department of Justice Office of Justice Programs National Institute of Justice will support research and development of roadside testing technologies for marijuana impairment. Funded at $595,000 under the National Institute of Justice Research, Evaluation, and Development Project Grants program (CFDA 16.560), the award running from January 1, 2023 to December 31, 2024 will support Immad of Quincy, MA in developing an easy-to-use, portable roadside device to test for...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $399,715.00 to Rescue Biomedical, LLC to develop and commercialize the Automatic Detection Device (AD2) component of their Automatic Antidote Delivery Device (A2D2). The AD2 is a user-centric wearable device that aims to automatically detect opioid overdose and respiratory depression, with the goal of reducing the need for intensive...